Trials / Not Yet Recruiting
Not Yet RecruitingNCT07361549
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment: A Randomized, Double-Blinded, Parallel Phase 2 Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Daniel A Tonetti, MD · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine (drug) | Intra-arterial lidocaine infusion into bilateral middle meningeal arteries |
| DRUG | Saline | Intra-arterial saline infusion into bilateral middle meningeal arteries |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2030-12-01
- Completion
- 2031-07-01
- First posted
- 2026-01-23
- Last updated
- 2026-01-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07361549. Inclusion in this directory is not an endorsement.